Wellogass-140
Composition: Simethicone 140 mg.
Packing: 10 × 5 blister.
View Product Details →
Looking for a Gynae PCD Pharma Franchise opportunity in India? Spencure Biotech offers a dedicated Wellisia product portfolio for business partners interested in the gynaecology and women’s healthcare segment.
Explore our range of tablets, capsules and other relevant formulations, and learn more about franchise opportunities, product availability and business support for your target market.
The gynaecology pharmaceutical segment includes products across several areas of women’s healthcare. For a pharma distributor, selecting a suitable portfolio and a dependable business partner is an important part of developing a long-term market presence.
Through its Wellisia division, Spencure Biotech presents a range of pharmaceutical products relevant to the gynaecology segment. Prospective franchise partners can review the portfolio, discuss local market requirements and enquire about available business opportunities.
Explore products across selected women’s healthcare and gynaecology-related categories to assess suitability for your market.
Review available tablets, capsules and other listed formulations when planning your product selection.
Contact Spencure to discuss product availability, territory options, commercial terms and the requirements for becoming a franchise partner.
Explore the following products listed in the Spencure Biotech portfolio. Open the individual product pages for additional information where available.
Composition: Simethicone 140 mg.
Packing: 10 × 5 blister.
View Product Details →Composition provided: Clindamycin I.P. 100 mg + Clotrimazole I.P. 100 mg + Tinidazole I.P. 100 mg.
Contact Spencure for complete product information and current availability.
Composition: Letrozole I.P. 2.5 mg.
Packing: 10 × 5 blister.
View Product Details →Composition provided: Calcium Carbonate I.P. 1250 mg + Vitamin D3 I.P. 2000 IU + Methylcobalamin.
View Product Details →Composition: Myo-Inositol USP 600 mg + Metformin HCl I.P. 500 mg (SR).
View Product Details →Composition: Cholecalciferol 60,000 IU.
Packing: 10 × 1 × 4 blister.
View Product Details →Composition: Dienogest I.P. 2 mg.
View Product Details →Composition: Medroxyprogesterone Acetate I.P. 10 mg.
View Product Details →Composition: Dydrogesterone 10 mg.
View Product Details →Composition: Azithromycin 1 g + Fluconazole 150 mg + Secnidazole 1 g, as a combination kit.
View Product Details →Refer to the product page or contact Spencure for the current composition and pack details.
View Product Details →Contact Spencure for verified composition, packing and product availability.
View Product Details →Refer to the product page for additional details and the current product information.
View Product Details →Contact Spencure for verified composition, packing and current availability.
View Product Details →Explore the product listing for further details on this formulation.
View Product Details →Composition: Nitrofurantoin I.P. 100 mg (SR).
View Product Details →Contact Spencure for the complete composition and current product details.
View Product Details →Composition: Estradiol Valerate 2 mg.
View Product Details →Composition: L-Methylfolate Calcium, Mecobalamin, Pyridoxal 5-Phosphate, DHA and Vitamin D3 (C.R.).
Packing information: 10 × 1 × 10, as supplied.
Contact Spencure for the product page and current availability.
If you are planning to enter the gynaecology pharmaceutical segment, start by evaluating your target market and discussing the available franchise options with Spencure Biotech.
Review the Wellisia portfolio and shortlist products relevant to your business plans.
Discuss your target territory, local market and product requirements.
Confirm eligibility, documentation, product availability and commercial terms.
Review the applicable agreement and regulatory requirements before starting business.
Explore the Wellisia product portfolio and connect with Spencure Biotech to enquire about franchise availability, territory options and business terms. Take the next step towards evaluating a women’s healthcare pharmaceutical business.
Enquire About Franchise OpportunitiesFind answers to common questions about selecting a gynaecology franchise partner.
A Gynae PCD Pharma Franchise is a business arrangement in which a pharmaceutical company authorises a partner to market and distribute its relevant products in an agreed territory, subject to the contract and applicable regulations.
Spencure Biotech lists products under its Wellisia division. Interested partners can review the available product portfolio and contact the company to confirm the latest range and supply availability.
The products listed on this page include formulations such as Welltrox-2.5, Myozed-1.1, Caldineo-XT, Dystra-10, Welligest-200 and other listed products. Confirm the approved indications, compositions and availability directly with Spencure before selecting products.
Investment depends on the selected product range, initial order, territory, business requirements and applicable commercial terms. Contact Spencure Biotech for current requirements rather than relying on a generic investment estimate.
You can enquire about territory availability and whether monopoly rights are offered for your proposed area. Any exclusivity should be confirmed in writing in the applicable agreement.
Review product quality documentation, licences, product availability, pricing, expiry and return policies, supply arrangements, territory terms and the written franchise agreement before making a decision.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.